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Abstract
Background:  The Tax oncoprotein of human T-cell leukemia virus type 1 (HTLV-1) is
leukemogenic in transgenic mice and induces permanent T-cell growth in vitro. It is found in active
CDK holoenzyme complexes from adult T-cell leukemia-derived cultures and stimulates the G1-
to-S phase transition by activating the cyclin-dependent kinase (CDK) CDK4. The Tax protein
directly and specifically interacts with CDK4 and cyclin D2 and binding is required for enhanced
CDK4 kinase activity. The protein-protein contact between Tax and the components of the cyclin
D/CDK complexes increases the association of CDK4 and its positive regulatory subunit cyclin D
and renders the complex resistant to p21CIP inhibition. Tax mutants affecting the N-terminus
cannot bind cyclin D and CDK4.
Results: To analyze, whether the N-terminus of Tax is capable of CDK4-binding, in vitro binding -
, pull down -, and mammalian two-hybrid analyses were performed. These experiments revealed
that a segment of 40 amino acids is sufficient to interact with CDK4 and cyclin D2. To define a Tax-
binding domain and analyze how Tax influences the kinase activity, a series of CDK4 deletion
mutants was tested. Different assays revealed two regions which upon deletion consistently result
in reduced binding activity. These were isolated and subjected to mammalian two-hybrid analysis
to test their potential to interact with the Tax N-terminus. These experiments concurrently
revealed binding at the N- and C-terminus of CDK4. The N-terminal segment contains the
PSTAIRE helix, which is known to control the access of substrate to the active cleft of CDK4 and
thus the kinase activity.
Conclusion: Since the N- and C-terminus of CDK4 are neighboring in the predicted three-
dimensional protein structure, it is conceivable that they comprise a single binding domain, which
interacts with the Tax N-terminus.
Background
The Tax protein of human T-cell leukemia virus type 1
(HTLV-1) is an essential regulator of viral replication and
a critical determinant of the HTLV-induced diseases. These
include the aggressive and fatal malignancy of CD4+ T-
lymphocytes termed adult T-cell leukemia (ATL) [1-3].
Several lines of evidence indicate that p40tax is the onco-
gene responsible for viral lymphocyte-transforming and
leukemogenic properties [4-7]. Mechanistically, several
biochemical features of the protein can cooperate to
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transform, among them transcriptional stimulation of cel-
lular signal transducers, cytokines [8-11] and anti-apop-
totic effectors. Tax' capacity to stimulate aneuploidy and
to interfere with DNA repair [12] could indirectly support
malignant progression. A major mechanistic explanation
for the mitogenic and immortalizing effects of the Tax
oncoprotein is provided by its ability to stimulate the G1-
to S-phase transition in T-cells [6,13-15].
In mammalian cells, G1-progression is controlled by the
sequential activation of several cyclin-dependent kinases
(CDKs), starting with CDK4, CDK6 and CDK2. Tax acti-
vates CDK4, CDK6 and CDK2 leading to phosphorylation
of retinoblastoma (Rb) tumor suppressor proteins and
liberation of the transcription factor E2F [6,16]. Moreo-
ver, Tax may also induce Rb degradation [17] and
increases cellular E2F synthesis [18,19]. Several indirect
effects of Tax and features of HTLV-infected cells may sup-
port the impact of Tax on CDK. For example, HTLV-1-
infected T-cells contain increased levels of cyclin D2
[16,20,21], which upon binding to CDK4 forms func-
tional holoenzyme complexes. Cyclin D2 expression is
upregulated by interleukin-2 receptor (IL2-R) signals [22-
24]. Tax may cooperate with interleukin-2 (IL-2) signaling
either indirectly through stimulating the expression of IL-
2Rα or directly by activating the cyclin D2 promoter
[21,25]. Furthermore, expression of CDK inhibitory pro-
teins, like p18INK4C [20], p19INK4D and p27Kip1[16,26] is
reduced in the presence of Tax. By contrast, the inhibitory
protein p21CIP1 is strongly upregulated in Tax-containing
cells [20,27]. Tax also represses the function of distinct
tumor suppressor proteins which interfere with G1- to S-
phase transition. These include p16INK4A, p15INK4B
[26,28,29] and p53 [30-35].
The protein-protein contact with the components of the
cyclin D/CDK complexes provides a major explanation
for the G1-phase stimulating effects of Tax. The Tax inter-
action with the CDK and cyclin component is direct and
specific. This interaction is detectable in vitro, in trans-
fected fibroblasts, HTLV-1-infected T-cells, and ATL-
derived cultures [36,37]. The Tax-CDK complex represents
an active holoenzyme. Direct association with Tax
enhances CDK4 activity. This increased kinase activity in
the presence of Tax may be explained by intensified asso-
ciation of CDK4 and its positive cyclin regulatory subunit
and by resistance of the complex to inhibition by p21CIP1
[36,37].
To understand the molecular mechanism of the Tax-medi-
ated CDK4 activation, the interacting domains of Tax and
CDK4 were characterized. Here we show that a segment of
40 amino acids derived from the N-terminus of Tax is suf-
ficient to bind CDK4 and cyclin D2. To define a Tax-bind-
ing domain, a series of CDK4 deletion mutants was tested
in different assays. These point at two regions derived
from the N- and C-terminus of CDK4 which upon dele-
tion consistently result in reduced binding capacity. The
potential of these isolated regions to interact with Tax was
demonstrated by mammalian two-hybrid analysis. These
experiments concurrently revealed Tax-binding at the N-
and C-terminus of CDK4.
Results and discussion
Capacity of the isolated N-terminus of Tax to bind cyclin 
D2- and CDK4
N-terminal Tax mutants bind neither CDK4 nor cyclin D2
and are incapable to stimulate CDK holoenzyme activity.
This indicates that the region is required for binding and
activation. To investigate whether this segment is also suf-
ficient for binding to cyclin D2 and CDK4, the coding
sequence of the N-terminal fragment (codons 1–40) was
cloned into the prokaryotic expression vector pET29b+
(Figure 1A). The corresponding protein (TaxM1-R40) and
Taxwt were produced in E. coli and coupled to S-protein
agarose (Figure 1B). To demonstrate direct interaction, in
vitro binding assays were performed. For this purpose, 35S-
labeled cyclin D2, CDK4 and, as a control, cyclin E were
synthesized  in vitro. All in vitro translation reactions
resulted in major bands of the expected size in equal
amounts (Figure 1C Input). Cyclin E was produced in two
previously observed isoforms [38]. Bands of minor inten-
sity are most probably due to incorrect in vitro translation
products and were ignored for quantitation. For binding
analysis aliquots of the agarose-coupled TaxM1-R40 and
Taxwt (Figure 1B) were incubated with the in vitro-trans-
lated proteins. As Figure 1C (Precipitation) shows, incu-
bation with TaxM1-R40 and Taxwt resulted in significant
amounts of cyclin D2 and CDK4. By contrast, both of the
cyclin E isoforms were significantly less precipitated.
Three independent experiments were quantitated. They
revealed a 3.5 – 5 fold increased protein binding of TaxM1-
R40 to CDK4 and cyclin D2 compared to the cyclin E con-
trol (Figure 1D). The binding to CDK4 of the N-terminal
peptide compared with full length Tax was slightly
reduced. This may indicate structure differences rather
than the contribution of other Tax regions in CDK4 bind-
ing. The interaction of the N-terminal Tax fragment with
cyclin D2 could be reproduced with natural folded pro-
teins in pull down experiments (Figure 1E). Cyclin D2-
and cyclin E-containing lysates derived from transfected
293T cells were incubated with bacterially expressed
TaxM1-R40 and Taxwt, immobilized on S-agarose (Figure
1B). Subsequent analysis of bound proteins by immuno-
blots revealed that the N-terminal Tax peptide interacted
with cyclin D2 but not with cyclin E. In summary, these
results demonstrate that a N-terminal peptide of Tax,
spanning amino acids 1 – 40, is sufficient for direct and
specific interaction with both, cyclin D2 and CDK4. These
results are in agreement with the capacity of the 40 N-ter-Retrovirology 2005, 2:54 http://www.retrovirology.com/content/2/1/54
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Binding of the isolated Tax N-terminus to CDK4 and cyclin D2 Figure 1
Binding of the isolated Tax N-terminus to CDK4 and cyclin D2. A) Physical map of Tax's functional domains and the 
position of the N-terminal peptide B) Taxwt and TaxM1-R40 were produced in E. coli and coupled to S-protein agarose. The figure 
depicts a coomassie brilliant blue-stained SDS-PAA gel loaded with the purified protein coupled to S-protein agarose and sam-
ples before and after induction with IPTG. C) CDK4, cyclin D2 and cyclin E were translated in vitro and incubated with S-agar-
ose coupled, E.coli-produced Taxwt and TaxM1-R40. Bound proteins were detected in gels by phosphoimaging (precipitation). 
To control for equal inset, aliquots of the radioactive proteins were subjected to gel electrophoresis (input). D) The radioac-
tive signals of bound proteins of two independent experiments were quantitatively evaluated. The figure depicts the mean rel-
ative binding. E) For in vivo pull-down analysis, cyclin D2 and cyclin E plasmids were transfected into 293T cells. Lysates were 
incubated with S-agarose coupled to Taxwt or the N-terminal peptide (TaxM1-R40). Bound proteins and aliquots of the lysates 
were subjected to gel electrophoresis and immunoblotting, using polyclonal cyclin D2 and cyclin E antibodies.Retrovirology 2005, 2:54 http://www.retrovirology.com/content/2/1/54
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minal amino acids of Tax to bind CDK4 in a yeast two-
hybrid system and in pull down analyses [39]. In exten-
sion, we demonstrated the interaction with naturally
folded CDK4 protein produced in human cells. The bind-
ing of both, CDK4 and cyclin D2, by this Tax domain
could cause a spacially close positioning of these proteins
and thus stimulate CDK4 – cyclin D2 holoenzyme forma-
tion. This could be part of the mechanistic explanation for
the enhancement of CDK4 kinase activity induced by a
synthetic N-terminal Tax peptide [39]. Furthermore, this
may explain the increased affinity of cyclin to CDK in the
presence of Tax [36]. In addition, Tax could influence
kinase activity through mediating cyclin phosphorylation
by its direct contact [14]. This phosphorylation appears in
cyclins which are actively complexed to cognate CDKs
[40,41] and may impair cyclin degradation via the ubiqui-
tin proteasome pathway [42].
Relevance of N- and C-terminal CDK4 regions for Tax-
binding in vitro
In order to understand whether domains, which are rele-
vant for regulating CDK4 activity, are affected by Tax, Tax-
binding CDK4 sequences were defined. For this purpose,
a series of deletion mutants was generated which cover the
complete coding region of CDK4 (Figure 2A). To identify
CDK4 sequences, which are relevant for Tax-binding in
the absence of other cellular components, in vitro binding
assays were performed. Aliquots of the S-protein agarose
matrix coupled Taxwt (Figure 1B) were incubated with the
in vitro-translated,  35S-labeled CDK4 mutants. Subse-
quently, Tax-bound CDK4 mutants were collected (Figure
2B Pull down). Equal inset of the in vitro-translated pro-
teins was verified (Figure 2B Input). As a background con-
trol, uncoupled S-protein agarose was incubated with the
in vitro-translated proteins. The immobilized proteins
were subjected to gel electrophoresis and quantitated by
measuring the radioactivity of the specific bands. To deter-
mine relative Tax-binding, the ratio between the specific
signal and the background was calculated. The results of
three independent experiments (Figure 2C) show reduced
relative binding compared to wild-type of three CDK4
deletion mutants in two regions. Two of them, CDK4dM1-
F31 and CDK4>dH30-V72, affected a N-terminal region. In
addition, a C-terminal mutant CDK4dL272-E303 did interact
at reduced levels with Tax. Thus, the N-terminal region
from amino acids 1–72 and the C-terminal region from
amino acids 272–303 of the CDK4 protein directly inter-
act with Tax. Alternatively, the deletion of these regions
may reduce the protein's affinity to Tax by affecting its
conformation.
Relevance of the N-terminal CDK4 domain for binding in 
vivo
In order to characterize CDK4 sequences relevant for in
vivo interaction, Tax and the CDK4 deletion mutants were
coexpressed in transfected 293T cells in equal amounts
(Figure 3A, lysates). Subsequently, coimmunoprecipita-
tion experiments were performed (Figure 3A, α-Tax-IP)
using a Tax-specific antibody. The resulting immunoblots
were stained with CDK4 and Tax-specific immune reac-
tions. These revealed a reduced affinity of Tax to some
mutants, in particular to CDK4dH30-V72 and CDK4dA182-
K211. To quantitate binding, the amounts of coimmuno-
precipitated CDK4- and Tax-proteins were determined.
The ration of both was taken as relative binding. The
mean from two independent experiments shows that
three CDK4 deletion mutants (CDK4dH30-V72, CDK4dS150-
R181, CDK4dA182-K211) in two regions have significantly
reduced binding affinity to Tax (Figure 3B). The mutants
CDK4dH30-V72 and CDK4dM1-F31, which also appears to be
reduced in binding, represent the same N-terminal region,
which was identified in the in vitro binding assays. In addi-
tion, two mutants in the central part of CDK4 (CDK4dS150-
R181, CDK4dA182-K211) resulted in reduced Tax binding.
Since this central region was not required in vitro, its dele-
tion may affect the CDK4 structure in vivo, thus rendering
it inaccessible for Tax-binding. The deletion of the C-ter-
minal amino acids (CDK4dL272-E303) did not affect Tax-
binding, indicating that this part is not essential for in
vivo-binding and may be replaced by cellular factors.
Moreover, this result may indicate that in vivo the N-termi-
nus is sufficient for Tax-binding. Thus, the in vivo binding
experiments confirmed the relevance of the N-terminal
CDK4 region for Tax-binding.
Tax-binding activity of isolated CDK4 regions in vivo
To investigate the affinity to Tax of those CDK4 regions,
which upon deletion affected Tax-binding, mammalian
two-hybrid assays were performed. All corresponding
CDK-sequences were cloned into the DNA-binding
domain containing vector(Figure 4A). The N-terminal
region, which was found to be important for Tax-binding
in vitro and in vivo, is included in plasmid pCDK4M1-V71.
The other regions, which affected Tax-binding in only one
assay, are represented by the constructs CDK4V242-E303 (C-
terminal region) and CDK4S150-K211 (central region). As a
control, CDK4L100-T149 was constructed, which contains a
region whose deletion did not affect Tax-binding in all
assays. In addition, the deletion mutant CDK4dH30-V72 was
inserted into the two-hybrid vector. The coding sequence
of the CDK4-binding Tax domain (amino acids M1 –
R40) was assembled into the DNA activation domain con-
taining other two-hybrid vector. To test for interaction,
human fibroblasts (293 cells) were co-transfected with
these constructs and luciferase assays were performed.
Whereas Firefly luciferase indicated the binding activity,
Renilla luciferase, which is constitutively expressed from
one plasmid, was analyzed as internal transfection con-
trol. Relative luciferase activity was calculated as the ratio
of Firefly to Renilla luciferase activity. The mean relativeRetrovirology 2005, 2:54 http://www.retrovirology.com/content/2/1/54
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Identification of a CDK4 region important for direct Tax interaction Figure 2
Identification of a CDK4 region important for direct Tax interaction. A) For binding assays, CDK4 mutants were 
constructed via PCR and cloned into the mammalian expression vector pcDNA3.1MycHis. B) CDK4 and its mutants were 
translated in vitro and reacted with S-agarose-coupled Taxwt. As a control, translated proteins were also incubated with uncou-
pled S-Agarose. Examples of resulting phosphorimager scans are shown. C) The diagram shows the mean Tax binding and 
standard deviation of three independent experiments that were quantitatively evaluated.Retrovirology 2005, 2:54 http://www.retrovirology.com/content/2/1/54
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Deletion of two regions in CDK4 interferes with Tax-binding in vivo Figure 3
Deletion of two regions in CDK4 interferes with Tax-binding in vivo. A) Tax and CDK4 mutants were coexpressed in 
transfected 293T cells. The complexes were immunoprecipitated by monoclonal Tax antibodies and protein A sepharose. To 
detect Tax-bound CDK4 mutants, complexes and lysate controls were subjected to gel-electrophoresis and Western blotting. 
One representative experiment is shown. B) Luminescence emitted by specific bands of two independent experiments was 
quantitative evaluated and the mean relative Tax binding was calculated.Retrovirology 2005, 2:54 http://www.retrovirology.com/content/2/1/54
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luciferase activity of three independent experiments is
shown in Figure 4B. Only two of the CDK4 constructs,
CDK4M1-V71  and CDK4V242-E303, yielded significant
amounts of relative luciferase activity, indicating direct
interaction with TaxM1-R40. This demonstrates that the N-
terminal region of CDK4 (peptide CDK4M1-V71), which
Interaction of CDK4 and Tax peptides in an eukaryotic two-hybrid assay Figure 4
Interaction of CDK4 and Tax peptides in an eukaryotic two-hybrid assay. A) The coding sequence of CDK4 peptides 
and a CDK4 deletion mutant were constructed via PCR and assembled into the GAL4 DNA-binding domain-expressing vector. 
The sequence of the CDK reactive N-terminus of Tax was inserted into the VP16 activation domain-expressing vector. B) To 
test for interaction, CDK4-containing plasmids were co-transfected with the Tax plasmid into 293 cells and luciferase assays 
were performed. The mean of three independent experiments is shown.Retrovirology 2005, 2:54 http://www.retrovirology.com/content/2/1/54
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upon deletion reduced binding affinity in vivo and in vitro,
bound TaxM1-R40 in the two-hybrid assay. In agreement
with the notion that the binding domain is absent, the
mutant CDK4dH30-V72, lacking 42 of these amino acids,
consistently showed no binding capacity in all assays. The
peptide CDK4S150-K211, which represents the CDK4 region
affecting Tax-binding exclusively in vivo, revealed no bind-
ing in the two-hybrid assay. In contrast, the C-terminal
peptide CDK4V242-E303, representing the region of CDK4
affecting Tax-binding in vitro, bound TaxM1-R40. In agree-
ment with the other assays, the peptide CDK4L100-T149 did
not bind. Taken together, the results of all binding assays
consistently identified the CDK4 N-terminus as main
interaction domain for Tax (Figure 5A). The CDK4 C-ter-
minus, which could directly interact with Tax, may coop-
erate with the N-terminus, although it was not essential
for Tax-binding in vivo.
To get an impression about the molecular interaction with
the folded protein, a three-dimensional structure of CDK4
was calculated (Figure 5B). It resembles the structure of
cdk2, which was determined from crystallized protein by
Model of Tax-CDK4 interaction Figure 5
Model of Tax-CDK4 interaction. A) Map of CDK4 regions relevant for Tax-binding. The N-terminal region of CDK4 is rel-
evant in all binding assays, suggesting that it is the major binding region. In addition, the C-terminus is considered as a second 
possible binding region. Red: regions, which upon deletion result in reduced binding; green: regions, which bind to Tax. B) Ter-
tiary structure prediction of CDK4. The structure was calculated from the amino acid sequence at Swiss Model http://swiss 
model.expasy.org. The resulting pdb file was visualized with rasmol. The prediction shows the proximity of N- and C-terminal 
regions in the folded CDK4 protein. Thus, it is conceivable that both represent a non-contiguous binding domain for Tax. Red: 
C-terminal segment; blue:N-terminal segmentRetrovirology 2005, 2:54 http://www.retrovirology.com/content/2/1/54
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X-ray diffraction [43]. As cdk2, the predicted structure is
bi-lobated, containing a β-sheet-rich N-terminal and a
alpha-helix-rich C-terminal region. This structure reveals
that the N- and C-terminus of CDK4 are neighbouring.
Thus, it is possible that both together provide a non-con-
tinuous binding domain for Tax. The N-terminus contains
the PSTAIRE helix of CDK4, which is part of the CDK's
cyclin D2 binding domain. Its rotation during the activa-
tion of CDK4 is required to unblock the catalytic cleft of
the kinase [44]. Binding of Tax to this region may influ-
ence its spacial arrangement. Thus, Tax in cooperation
with cyclin D2 could support formation of the active con-
formation and stimulate CDK4 activity by influencing the
PSTAIRE helix.
Conclusion
The 40 N-terminal amino acids of Tax are sufficient to
bind cyclin D2 and CDK4. Within CDK4 a N- and a C-ter-
minal domain are relevant for Tax binding. These
domains are neighbouring in the predicted three dimen-
sional protein structure. Taken together, these findings
suggest that Tax stimulates G1- to S-phase transition by
supporting the association of CDK4 and cyclin D2. Fur-
thermore, they support the conclusion that CDK4 activity
is stimulated through conformational changes of the
enzyme directly mediated by Tax.
Methods
Generation of CDK4 deletion mutants
All CDK4 deletion mutants were generated via PCR [45].
In order to introduce the internal deletions, 16 different
primers were used, two outside 28-mer oligonucleotides
spanning the 5' and 3' ends of the CDK4 open reading
frame (CDK4S and CDK4AS) and 14 chimeric oligonucle-
otides designed to carry the 5' and 3' sequences flanking
the deleted regions. After three rounds of PCR with Pwo
polymerase (Roche, Mannheim, Germany), the deleted
clones CDK4dH30-V72, CDK4dV70-L100, CDK4dR101-L120,
CDK4dM121-S150, CDK4dS150-R181, CDK4dA182-K211,
CDK4dK211-D241, CDK4dV242-M275 were created. To engineer
the N- terminal CDK4dM1-F31 and C-terminal CDK4dL272-
E303 deletion clones, one round of PCR was performed by
using an internal 5' primer or 3' primer in combination
with the corresponding outside primer. To engineer the
CDK4 full length construct one round of PCR was per-
formed with the outside primers. The resulting PCR prod-
ucts were digested with BamHI and HindIII and ligated via
these sites into the pcDNA3.1(-)/Myc-His A expression
vector (Invitrogen, Karlsruhe, Germany). The resulting
clones were verified by nucleotide sequencing.
Coimmunoprecipitation
Human 293T cells were kept and transfected for coimmu-
noprecipitations as described [36]. Briefly, cells were lysed
in buffer containing 50 mM Tris, 150 mM NaCl, 0.2%
Tween 20, 1 mM dithiothreitol, 1 mM phenylmethylsul-
fonyl fluoride and 10 µg/ml aprotinin. To immunoprecip-
itate Tax and associated proteins cleared protein
supernatant (0.7 to 1 mg whole protein) were incubated
for 1 h at 4°C with 1 µg of monoclonal Tax antibody and
the immune complexes were collected by protein A-
Sepharose CL4B (Pharmacia) beads (1 h at 4°C). Beads
with the precipitated proteins were washed three times
with lysis buffer. An aliquot of protein supernatant was
taken as lysate control (40 µg whole protein). Immuno-
precipitates and lysate controls were separated on gels and
electro-blotted. Subsequently, membranes were
incubated with 5% nonfat dry milk to block unspecific
binding before reacting them with a 1: 200 dilution of
monoclonal Tax antibody for 1 h at room temperature.
Membranes were washed and incubated with a 1:2.500
dilution of an anti-mouse immunoglobulin G-horse-rad-
ish peroxidase conjugate (Amersham, Freiburg, Ger-
many). Bound antibodies were visualized with an
enhanced chemiluminescence detection system (Amer-
sham) and CCD-camera. The luminescence of specific
bands was quantitated from the digitalized image by
using the program AIDA (raytest Isotopenmeßgeräte
GmbH, Straubenhardt, Germany).
In vitro binding and pull down assays
35S-methionine labeled CDK4 and mutants were pro-
duced in vitro with a rabbit reticolocyte-based in vitro tran-
scription/translation system (Promega, Mannheim,
Germany). To prevent the expression of the myc/his-tag,
the inset plasmids were digested with HindIII  prior to
translation. Tax was produced in E.coli and coupled to S-
protein-agarose as previousely described [36]. For a bind-
ing assay 5–10 µl of the in vitro-translated protein was
diluted in 500 µl of RIPA buffer (10 mM Tris [pH 7.4], 150
mM NaCl, 2 mM EDTA, 1 % Nonidet P-40, 0.5 % desox-
ycholat, 0.1 % sodium dodecyl sulfate). An aliquot of 10
µl was taken as an inset control. The S-protein-agarose-
bound Tax protein (15 µl) was incubated with the radio-
active proteins for 1 h at 4°C, washed with RIPA-buffer
and recovered by boiling the beads in loading buffer. Pro-
teins were sized on an SDS-12% polyacrylamide gel,
quantitated and visualized by a phosphorimager.
TaxM1-R40 was generated via PCR, using the primers TaxM1-
R40 -pet-S and TaxM1-R40 -pet-AS and plasmid pcTax [46] as
template. Resulting PCR products and the pet 29b + vector
(Novagen, Bad Soden, Germany) were digested with
BamHI and HindIII and ligated. Resulting clones were ver-
ified via sequencing. Cyclin D2 and cyclin E were trans-
fected in 293T cells and lysates were prepared as
previously described [36]. A lysate control was performed
with 40 µg whole protein. Lysates containing 0.5 – 1 mg
whole protein were incubated with E.coli-produced Taxwt
or TaxM1-R40, coupled to Ni-NTA agarose for 1 h, washedRetrovirology 2005, 2:54 http://www.retrovirology.com/content/2/1/54
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with lysis buffer and recovered by boiling the beads in
loading buffer. Proteins were sized on a 12%-SDS-PAA
gel, transferred onto a nitrocellulose transfer membrane
and stained with specific antibodies.
Mammalian two-hybrid assay
All constructs for mammalian two-hybrid assay were gen-
erated via PCR. The TaxM1-R40 construct PCR was per-
formed with the primer TaxM1-R40 -M2H-S and TaxM1-R40 -
M2H-AS using the plasmid pcTax as a template. For the
CDK4 constructs CDK4dV70-L100 the pcDNA3.1(-)/Myc-His
A construct was used as a template. The resulting PCR
products were digested with KpnI and XbaI. For the other
CDK4 constructs CDK4M1-V71,  CDK4L100-T149,  CDK4S150-
K211 and CDK4V242-E303 the CDK4 full length pcDNA3.1(-)/
Myc-His A construct was used as template. The resulting
PCR products were digested with BamHI and XbaI. The
digested products were ligated into the vectors pBind and
pAct (CheckMate Mammalian two-hybrid system,
Promega). The vector pG5luc contains the reporter gene
(Firefly luciferase). Human 293 cells were transfected with
the plasmids using Lipofectamine reagents (Invitrogen).
The luciferase-assay was performed with the Dual-Luci-
ferase reporter assay (Promega) using a microplate
luminometer.
Oligonucleotides
Designation for primers correspond to the plasmid
names. The oligonucleotides sequences were as follows:
CDK4S, 5'-ATTTACGGATCCACCATGGCTACCTCTC-3'
(outer primer);
CDK4AS, 5'-ATCCCCAAGCTTCTCCGGATTACCTTCA-3'
(outer primer);
CDK4dM1-F31S, 5'-ATTTACGGATCCATGGTGGCCCT-
CAAGA-3';
CDK4dH30-V72S, 5'-CACAGTGGCCACTTTGTCCG-
GCTGSTGGAC-3';
CDK4dH30-V72AS, 5'-GTCCATCAGCCGGACAAAGT-
GGCCACTGTG-3';
CDK4dV70-L100S, 5'-GCTTTTGAGCATCCCAATAGGACAT-
ATCTGGACAAG-3';
CDK4dV70-L100AS, 5'-CTTGTCCAGATATGTCCTATT
GGATGCTCAAAAGC-3';
CDK4dM121-S150S, 5'-GAAACGATCAAGGATCTGGGT-
GGAACAGTCAAGCTG-3';
CDK4dM121-S150AS, 5'-CAGCTTGACTGTTCCACCCA-
GATCCTTGATGGTTTC-3';
CDK4dS150-R181S, 5'-AACATTCTGGTGACAAGTGTTA-
CACTCTGGTACCGA-3';
CDK4dS150-R181AS, 5'-TCGGTACCAGAGTGTAACACTT-
GTCACCAGAATGTT-3';
CDK4dA182-K211S, 5'-GCTCCCGAAGTTCTTCT-
GCCTCTCTTCTGTGGAAAC-3';
CDK4dA182-K211AS, 5'-GTTTCCACAGAAGAGAGGCAGAA-
GAACTTCGGGAGC-3';
CDK4dK211-D241S, 5'-GCAGAGATGTTTCGTCGAGATG-
TATCCCTGCCCCGT-3';
CDK4dK211-D241AS, 5'-ACGGGGCAGGGATACATCTC-
GACGAAACAGCTCTGC-3';
CDK4dV242-M275S, 5'-GATGACTGGCCTCGAGATCT-
GACTTTTAACCCACAC-3';
CDK4dV242-M275AS, 5'-GTGGGTGTTAAAAGTCAGATCTC-
GAGGCCAGTCATC-3';
CDK4dL272-E303AS, 5'-ATTTAGAAGCTTCAGCAGCTGT-
GCTCCC-3';
TaxM1-R40  -M2H-S, 5'-TCATCTAGAATGGCCCATTTC-
CCAGGGTT-3'(outer primer);
TaxM1-R40 -M2H-AS, 5'-ATTGGTACCTAGGCGGGCCGAA-
CATAGTC-3'(outer primer);
CDK4-M2H-S, 5'-CCTTGGATCCTAATGGCTACCTCTC-
3'(outer primer);
CDK4-M2H-AS, 5'-GCATTCTAGACGCCTCCGGATTAC-
CTT-3'(outer primer);
CDK4M1-V71-AS, 5'-GCATTCTAGACGCAACATTGGGAT-
GCTCAAA-3';
CDK4L100-T149-S: 5'-CCTTGGATCCTACTAAGGACAT-
ATCTGGAC-3';
CDK4L100-T149-AS: 5'-GCATTCTAGACGCTGTCACCA-
GAATGTTCTC-3';
CDK4S150-K211  -S: 5'-CCTTGGATCCTAAGTGGT-
GGAACAGTCAAG-3';Retrovirology 2005, 2:54 http://www.retrovirology.com/content/2/1/54
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CDK4S150-K211  -AS: 5'-GCATTCTAGACGCCTTTCGAC-
GAAACATCTC-3';
CDK4V242-E303-S: 5'-CCTTGGATCCTAGATGTATCCCT-
GCCCCGT-3';
TaxM1-R40  -pet-S: 5'-GATCGGATCCGATGGCCCATTTC-
CCAGGGTT-';
TaxM1-R40  -pet-AS: 5'-CTAATTAAGCTTTAGGCG-
GGCCGAACATAGTCCCCCAGAGATG-3',
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